• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    eBook
    Top Features
    Metallic Make Up for Orthopedic Materials

    Infection Control Strategies Offer a Plan of Pathogen Attack

    Multi-Dimensional Approaches to Orthopedic Implant Manufacturing

    Orthopedic Implants Are Fit to Print

    Fitting the Mold of Ortho Device Manufacturing
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Orthobiologics Market to Top $10.3 Billion by 2030

    Artelon Granted U.S. FDA 510(k) Clearance for FlexBand, FlexPatch & FlexBand Plus

    Synergy Spine Solutions Completes Enrollment in IDE Clinical Trial

    Biocomposites Acquires Artoss, Maker of NanoBone Bone Graft Substitute

    Nevro Names Stryker Exec Greg Siller as Chief Commercial Officer
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    Former BD, J&J Executives Join Acuitive Technologies Board

    Augmedics Debuts New Features, Indications for xvision Platform

    Artelon Closes $20M Series B Funding

    Orthofix Unveils Seven-Year Outcome Data for M6-C Artificial Cervical Disc

    The Silicon Valley Bank Collapse and Its Impact on Compliance
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    3D Printing Provides Stepping Stones for New Orthopedic Footwear Innovations

    How Honeywell's Spectra Fiber is Used in Orthopedics, TAVR, and More

    All About Reverse Shoulder Devices: Analyzing the Factors Driving Their Popularity

    Evolution of the Global Orthopedic Biomaterials Market

    Industry Innovation: A Look at Regenerative Medicine in Orthopedics
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Modern Plastics

    Life Science Outsourcing Inc.

    AV&R

    Braxton Manufacturing

    Tiodize
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • eBook
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Features

    Realizing the Promise of Pre-Validated Packaging

    Balancing product quality, patient safety, and faster time to market is possible—it takes careful consideration in packaging design and validation.

    Realizing the Promise of Pre-Validated Packaging
    Class 10,000/ISO 7 cleanroom medical device assembly and packaging operations. Image courtesy of Millstone Medical.
    Ben White, Engineering Manager, Business Development, Millstone Medical Outsourcing02.13.19
    Time to market is critical to success for OEMs when it comes to launching new product lines and devices. Yet, despite the pressure and desire to speed time to market, an OEM can never lose sight of the top priorities of product quality and patient safety. The risk is otherwise continual, and unanticipated delays can impact product launches; or, in worst-case scenarios, new technologies never reach the market at all. With the rise of robust pre-validated packaging and universal packaging solutions, preserving quality while cutting time to market by up to 50 percent is possible. This article examines the rise of pre-validated and universal packaging solutions, the promise of compressed product launch timelines, and the risk mitigation these options offer.

    Increased Scrutiny for a Growing Market
    The medical implants market is growing rapidly, projected to garner $116 billion by 2022.1 Orthopedic implants represent the largest growth sector of this market, as an increasing number of patients ages 55+ worldwide opt for surgeries that improve and extend quality of life. An increase in the aging population of the United States as well as increased adoption in markets around the world, such as Asia, are contributing to worldwide growth in the orthopedic implant market. In response to this growth as well as to technological advancements that fuel innovation, new product development proliferates, from the creation of patient-specific implants to the application of 3D technology and sculptural computer-aided design.

    As the market has grown, scrutiny and regulatory oversight has increased, which compounds the complexity in process and package validation. The FDA has established classification for nearly 2,000 medical devices, sorting them into three regulatory classes based on the level of control considered necessary to ensure device safety and effectiveness in patients. At the same time, scrutiny of the impact of devices on patients and patient safety has increased, with the FDA focusing on objective evidence from OEMs on each portion of the validation process to be in compliance. In addition, significant revisions to ISO 11607 have been made for the first time in more than a decade, necessitating an increased focus on materials selection, design, process, and quality controls. For a final layer of complexity in an already complex landscape, individual OEMs may approach package validation differently, based on how they individually interpret ISO regulations.

    As a result, packaging design and validation is a multifaceted process that can take significant time and planning, increasing time to market for OEMs. In some cases, the time required for package design and validation can be 12 to 18 months, or even longer. A new package design process offers no guarantees; just because an OEM is spending valuable time and resources designing a package doesn’t mean that package is in fact going to pass validation.

    A Brief Overview of Package Validation
    Package validation is the process of creating and ensuring the integrity of a sterile package for an implant’s transfer from manufacturer to patient. After all, implants must enter and exist within the human body without negative patient implications. To safeguard patient safety, package validations ensure implants withstand transportation to the operating room with effective aseptic transfer into the surgical suite and into patients’ bodies. Package validation is also mandatory for compliance with regulatory oversight and global standards that govern packaging, such as the ISO 11607 standard (Parts 1 and 2).

    The ISO 11607 standard defines three key components of a validated packaging system:
    • Package system design and development, including materials selection, design, and packaging system design qualification testing
    • Qualification, validation, and proof of stability of sterile barrier system (SBS) materials and seals
    • SBS sealing process validation
    With traditional custom package design and validation, interpretation of and compliance with the complex ISO 11607 standard presents a challenge, as it introduces myriad possibilities for error or delay in the validation process. In a rapidly growing and competitive market, delays in product launches have high stakes: losing first-mover advantage or introducing significant delays that can affect a manufacturer’s ability to recoup R&D costs.

    A standard validation process follows an installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ). To illustrate, consider the sealing process, which is necessary to create the sterile barrier. The sealing IQ ensures the sealing equipment is installed and operates properly. After a thorough design of experiment (DOE) to determine viable input parameters, an OQ is conducted to test the sealing process at certain challenge conditions. The sealing PQ tests nominal parameters for effective, reproducible results with induced variability (e.g., multiple operators, product lots, shifts, etc.).

    Challenging a sealing process is based on a variety of inputs and controls, such as a selection of representable product, sealing equipment controls (e.g., temperature, pressure, dwell time, etc.). In short, all qualifications are executed to provide sufficient confidence and evidence that patient risk is mitigated.

    Best Practice: A Holistic Approach to Product and Packaging Design
    With so many layers of complexity and so much pressure on reaching the market quickly and safely, OEMs face an uphill climb when it comes to design and validation. To mitigate risk, prioritize patient safety, and speed time to market, it’s essential to consider product and package design as two parts of a whole.

    In an ideal scenario, an OEM takes a holistic approach, simultaneously developing the device while determining how to design its package and handle the validation process successfully. Considerations of the stresses of distribution as well as the aseptic transfer within the surgical suite are present throughout the design process.


    Figure 1

    Traditional custom package validation falls into three phases (Figure 1):
    • Process validation, which proves that a sterile barrier can be created.
    • Package design, which is event-related and concerns whether or not the design enables the device to survive distribution with an integral sterile barrier from distribution through the arrival in the operating room.
    • Package stability, which is time-related and entails proving the packaging maintains its integrity for the shelf life determined by the OEM. Proof of this can be addressed through accelerated aging techniques—if a product will have a shelf life of five years, it’s not necessary for the OEM to wait the full five years. Instead, accelerated aging can simulate the aging process and provide the necessary proof.
    Despite the advantages it offers, a holistic approach is not always taken by OEMs during their product launches. By not considering product and package as a whole until late in the product design process, many OEMs unnecessarily or inadvertently extend the validation process, and, therefore, increase time to market.

    Cutting Time to Market
    Traditionally, accelerating time to market has hinged on preparation and process organization, even in the best cases when product and package design are considered holistically. OEMs and sterile package manufacturers must choose a sterile barrier system, define a cleaning and sterilization process, and undergo distribution and aging testing.

    Depending on the approach to distribution and accelerated aging testing an OEM takes, the validation timeframe can be 26 weeks or more. The rise of robust solutions for pre-validated and universal packaging configurations can eliminate up to 13 weeks from a typical validation timeline, cutting time to market by 50 percent (Figure 2).


    Figure 2

    Six Key Validation Benefits to OEMs
    The rise of pre-validated and universal package configurations introduces an array of benefits and efficiencies for OEMs when it comes to the validation process.

    1. Reduced risk: First and foremost, pre-validated packaging greatly reduces risk in the validation process when compared to custom validated packaging. As noted earlier, package design comes with no guarantee when it comes to validation, and there are many points in the process where a package can fail an associated validation. Examples include pain points on a device and even the parameters utilized in the accelerated aging process, such as testing with aggressively high temperature ranges. Because pre-validated packaging is, by its very nature, already validated, an OEM has the assurance a sterile barrier has been created and it can be maintained; and the package has withstood the rigors of distribution and aging testing. Key knowledge of the factors involved in successfully completing distribution and accelerated aging testing also goes into the design of certain pre-validated and universal packaging solutions. For instance, understanding the change of pressure that a device will experience in airplane transit, or the shock stress of transportation by a truck, can be incorporated into pre-validated designs, heading off the potential for these distribution stresses to delay time to market in custom packaging design. Similarly, thorough understanding of optimal temperature and humidity ranges for accelerated aging testing can avoid unnecessary delays in the validation process.
    2. Flexible package design: Certain solutions offer flexible package designs with a validated sterile barrier or sealing flange and can be used for a variety of spine and orthopedic designs. Whether an OEM chooses a pouch or tray design (Figure 3), manipulation of an inner insert or the geometry within the sterile barrier can accommodate a wide range of product SKUs within one single type of pre-validated sterile package. Flexibility in package design can be especially beneficial to small or medium-sized OEMs that might not have a large product engineering and design staff and where resources may be spread more thinly. For these manufacturers, a pre-validated option with inserts sized specifically to accommodate particular products of different sizes in a product line significantly speeds time to market while saving costs. Products can be packaged in trays or pouches within an outer package that has a pre-validated sterile barrier. It’s critical to understand how a device will be used in a clinical setting to choose between a pouch or tray package configuration. A tray is advantageous to minimize the possible spread of bacteria during the aseptic transfer, for example. In situations where the entire package is introduced to the sterile field, rather than just its contents, an inner/outer package configuration is required.
    3. Flexibility in sterilization method: Pre-validated packaging also offers flexibility in the method used for sterilization, accommodating gamma, ethylene oxide (EO), or E-beam sterilization pending specific product needs. For instance, sterilization by EO requires a semi-permeable sterile barrier, which allows the sterilization gas to enter the packaging. Pre-validated solutions that factor in such detail can stave off significant delays in the validation process.
    4. Resource efficiencies: Pre-validated packaging introduces several areas for resource efficiencies. Approaching the process with a universal packaging design allows for use by multiple product families independent of geometry and weight. In addition, a pre-validated or universal solution can mean fewer materials are needed, simplifying the supply chain and introducing greater certainty when it comes to materials use. A consolidated package design can also reduce the number of decisions an OEM or its staff faces when it comes to packaging, material, and the validation process.
    5. Reduced costs: Pre-validated packaging reduces upfront costs while managing risk. If, for instance, an OEM introduces additional SKUs with the same materials and parameters as devices that previously passed validation, the same type of pre-validated packaging solution can be used. As a result, the necessity for repetitive testing, which adds time and cost to the validation process, can be reduced or eliminated.
    6. Mistake-proofing: Pre-validated packaging can reduce or eliminate the potential for human error, which can in turn cut risk and improve quality assurance. For instance, under pressure to get to market, custom package design can sometimes result in the design of multiple trays and lids, which can be put together in incorrect configurations. Certain pre-validated or universal packaging solutions have been designed so that there is only one way to assemble the final package, mistake-proofing the process and introducing operator efficiency while also reducing risk.

    Figure 3

    A Solution for Remediated Packaging
    In some cases, an OEM becomes mired in the package design and validation process. This can happen as a result of quality or design gaps, or because of an in-depth FDA audit that flags issues with compliance. It can also happen when package validation keeps failing at a specific point in the process, for example in accelerated aging, when the OEM introduces parameters that a package cannot withstand in an effort to compress accelerated aging timelines and get to market more quickly.

    In these cases, pre-validated packaging, especially a solution offered by an industry expert, can prove beneficial. Package design and validation is outsourced, and the vendor or partner can remediate the process with pre-validated packaging that gets the product into compliance—and to market—more quickly. 

    Considerations and Concerns
    The use of pre-validated packaging or universal packaging solutions, of course, doesn’t eliminate the necessity for ongoing operational qualification and performance qualification, essential components of compliance with ISO 11607. Ensuring all validation data is maintained in an OEM’s design history file is essential because, of course, a manufacturer is ultimately responsible when it comes to compliance, an audit, a recall, or any other adverse event.

    Why Outsource Package Validation?
    For OEMs, balancing time to market with product safety can feel like a tug of war. The complexities of package design and validation and the rigors of maintaining ISO standards in the process can drive up headcount, operating, and fixed costs.

    Outsourcing to an industry partner with market expertise in packaging design and validation allows OEMs to focus where they excel—on creating great products that improve patients’ lives. Pre-validated packaging can enable OEMs to safely deliver products to market faster and increase OEMs’ confidence in the quality of the finished goods. At the same time, outsourcing can manage the risk of validation and ensure there are no regulatory constraints or delays. It can also alleviate some of the challenges a manufacturer faces in proving it maintains a validated state. On a broader scale, outsourcing also frees resources and talent to focus on an OEM’s core competencies of product design, marketing, and sales, fueling growth in the customer base and the business overall.

    There’s an additional consideration when it comes to the expertise made available to an OEM through outsourcing. Access to the latest perspective and industry best practices on the interpretation of ISO standards, the current state of the regulatory landscape, and the latest FDA activities gives OEMs invaluable insight on strategy for current as well as future products.

    Conclusion
    Robust pre-validated and universal packaging configuration solutions offer a great deal of promise for manufacturers in balancing patient safety with time-to-market considerations. In reducing risk, cost, and unnecessary delay while introducing cost efficiencies, pre-validated packaging can help OEMs better navigate the challenge of taking an optimal and holistic approach to product and packaging design. 

    Reference
    1 http://bit.ly/odt190140

    Ben White is the engineering manager for business development at Millstone Medical Outsourcing. He has been with the company for five years in roles in quality and validation engineering. Through partnerships with top orthopedic companies, White’s team stands at the forefront of industry regulations regarding sterile packaging, end of line cleaning, and sterilization.
    Related Searches
    • patient
    • orthopedic implant market
    • iso
    • development
    Suggested For You
    Millstone Medical Outsourcing Millstone Medical Outsourcing
    Squeaky Clean: Orthopedic Device Packaging & Sterilization Squeaky Clean: Orthopedic Device Packaging & Sterilization
    Getting a Clinical Viewpoint Getting a Clinical Viewpoint
    2019: The Year to Enhance Quality in Orthopedic Product Development 2019: The Year to Enhance Quality in Orthopedic Product Development
    FDA Clears SpinalCyte IND Application for Universal Donor Cell Therapy to Treat Lower Back Pain FDA Clears SpinalCyte IND Application for Universal Donor Cell Therapy to Treat Lower Back Pain
    FDA OKs Additive Orthopaedics FDA OKs Additive Orthopaedics' Patient-Specific 3D Printed Locking Lattice Plates
    Material Matters: New Offerings for Orthopedic Technologies Material Matters: New Offerings for Orthopedic Technologies
    MDSAP Audits Update: Progress, Challenges, and a Cost Reduction Case Study MDSAP Audits Update: Progress, Challenges, and a Cost Reduction Case Study
    Data Monitoring Committees: Making DMCs Work for Your Study Data Monitoring Committees: Making DMCs Work for Your Study
    Practice Makes Perfect...Virtually Practice Makes Perfect...Virtually
    FDA Plans to Modernize 510(k) Program FDA Plans to Modernize 510(k) Program
    Zimmer Biomet Spine Announces FDA Approval of Mobi-C Cervical Disc Labeling Extension Zimmer Biomet Spine Announces FDA Approval of Mobi-C Cervical Disc Labeling Extension
    Do New Structures Redefine Do New Structures Redefine 'Material'?
    1. Stryker Corp. 1. Stryker Corp.
    New Technologies Reshape Orthopedic Design New Technologies Reshape Orthopedic Design

    Related Buyers Guide Companies

    • Millstone Medical Outsourcing

      Millstone Medical Outsourcing

      ...
      Brittany arnone, marketing manager 06.01.23

    • Packaging & Sterilization
      Squeaky Clean: Orthopedic Device Packaging & Sterilization

      Squeaky Clean: Orthopedic Device Packaging & Sterilization

      A variety of industry experts discuss the trends, challenges, and future of orthopedic and medical device packaging and sterilization.
      Sam Brusco, Associate Editor 02.13.19

    • 3-D Printing/Additive Mfg. | Biologics | MIS/Robotics
      Getting a Clinical Viewpoint

      Getting a Clinical Viewpoint

      ...
      Sean Fenske, Editor-in-Chief 02.13.19


    • Software & Quality
      2019: The Year to Enhance Quality in Orthopedic Product Development

      2019: The Year to Enhance Quality in Orthopedic Product Development

      ...
      Anthony Parise, Product Strategist—Life Sciences, ETQ 02.13.19

    • Spine/Neurology
      FDA Clears SpinalCyte IND Application for Universal Donor Cell Therapy to Treat Lower Back Pain

      FDA Clears SpinalCyte IND Application for Universal Donor Cell Therapy to Treat Lower Back Pain

      Acceptance of double blind degenerative disc disease data is strong signal for company’s development path.
      Business Wire 01.18.19

    Loading, Please Wait..

    Trending
    • Treace To Buy RPM-3D Tech For Up To $30 Million
    • Nevro Names Stryker Exec Greg Siller As Chief Commercial Officer
    • FDA Approves Centinel Spine's Two-level Prodisc L Total Disc Replacement
    • Cementless Hip Implants Are Gradually Losing Their Popularity In Europe
    • Spineart, ECential Robotics Begin Partnership
    Breaking News
    • Orthobiologics Market to Top $10.3 Billion by 2030
    • Artelon Granted U.S. FDA 510(k) Clearance for FlexBand, FlexPatch & FlexBand Plus
    • Synergy Spine Solutions Completes Enrollment in IDE Clinical Trial
    • Biocomposites Acquires Artoss, Maker of NanoBone Bone Graft Substitute
    • Nevro Names Stryker Exec Greg Siller as Chief Commercial Officer
    View Breaking News >
    CURRENT ISSUE

    May/June 2023

    • Metallic Make Up for Orthopedic Materials
    • Infection Control Strategies Offer a Plan of Pathogen Attack
    • Multi-Dimensional Approaches to Orthopedic Implant Manufacturing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Sempera Organics and Alchemist Labs Announce Partnership for Mushroom Testing
    Nektium Expands International Distribution Network for Botanical Extracts
    Kemin Receives Positive EFSA Opinion for BetaVia Pure, its Beta-Glucan Ingredient
    Coatings World

    Latest Breaking News From Coatings World

    Aramsco Acquires Pantheon Surface
    American Chemistry Council Recognizes Covestro for Sustainability Leadership
    PPG Launches Low-temperature Cure Electrocoats for Automotive Manufacturers
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Denise Wocko Named Head of Global Client Portfolio Management at RQM+
    FDA Clears Nova Eye Medical's iTrack Advance Canaloplasty Device
    Olympus to Establish Digital Excellence Centers
    Contract Pharma

    Latest Breaking News From Contract Pharma

    MilliporeSigma Announces Proteologix as Winner of North American Biotech Grant
    Veeva Business Consulting Expands with New R&D Services
    Samsung Biologics Accelerates Timeline of New Fifth Plant
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    GetHarley Raises $52 Million in Latest Funding Round
    Refillable Skincare Products Face Hurdles Despite Growing Sustainability Awareness
    La Roche-Posay Introduces Niacinamide 10 Serum
    Happi

    Latest Breaking News From Happi

    La Roche-Posay Expands Anti-Aging Collection with Niacinamide 10 Serum
    Rite Aid Launches Beauty and Personal Care Essentials Collection
    Proven Skincare Granted Second Personalization Patent
    Ink World

    Latest Breaking News From Ink World

    Pigments Market to Reach $26,598 Million by 2022: AMR
    Evonik Launches New TEGO Rad 2550 Slip and Defoamer Additive
    HM Document Solutions Acquires Two Xeikon SX30000 Digital Presses
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    CCL to personalize online customer experience
    Michelman named recipient of IRI Excellence Award for Corporate Citizenship
    Registration opens for rebranded FTA Fall Technical Conference 2023
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    TechnoPlants to Exhibit at ITMA
    Andritz Buys 100% Stake in Dan-Web
    Luminy PLA Meets EU Sustainability Regulations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthobiologics Market to Top $10.3 Billion by 2030
    Artelon Granted U.S. FDA 510(k) Clearance for FlexBand, FlexPatch & FlexBand Plus
    Synergy Spine Solutions Completes Enrollment in IDE Clinical Trial
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Christoph Ostermann Named Chairman of Heliatek‘s Advisory Board
    Flexible and Printed Electronics Represented at productronica 2023
    IMI Europe Announces InnoLAE 2024

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login